nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB1—Mitomycin—urinary bladder cancer	0.0804	0.165	CbGbCtD
Chlorpromazine—BCHE—Cisplatin—urinary bladder cancer	0.0663	0.136	CbGbCtD
Chlorpromazine—ABCB11—Doxorubicin—urinary bladder cancer	0.0658	0.135	CbGbCtD
Chlorpromazine—ALB—Fluorouracil—urinary bladder cancer	0.0379	0.0776	CbGbCtD
Chlorpromazine—CYP3A4—Thiotepa—urinary bladder cancer	0.0365	0.0749	CbGbCtD
Chlorpromazine—CYP2E1—Etoposide—urinary bladder cancer	0.0327	0.067	CbGbCtD
Chlorpromazine—ADRA1B—vas deferens—urinary bladder cancer	0.0298	0.147	CbGeAlD
Chlorpromazine—ABCB1—Gemcitabine—urinary bladder cancer	0.0232	0.0475	CbGbCtD
Chlorpromazine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0226	0.0464	CbGbCtD
Chlorpromazine—ALB—Methotrexate—urinary bladder cancer	0.0209	0.0428	CbGbCtD
Chlorpromazine—CYP1A2—Etoposide—urinary bladder cancer	0.0189	0.0387	CbGbCtD
Chlorpromazine—HTR7—vas deferens—urinary bladder cancer	0.0173	0.0857	CbGeAlD
Chlorpromazine—ABCB1—Cisplatin—urinary bladder cancer	0.0168	0.0345	CbGbCtD
Chlorpromazine—ABCB1—Etoposide—urinary bladder cancer	0.0165	0.0339	CbGbCtD
Chlorpromazine—CHRM3—ureter—urinary bladder cancer	0.0139	0.0689	CbGeAlD
Chlorpromazine—SMPD1—urine—urinary bladder cancer	0.0122	0.0602	CbGeAlD
Chlorpromazine—ABCB1—Doxorubicin—urinary bladder cancer	0.0113	0.0231	CbGbCtD
Chlorpromazine—ABCB1—Methotrexate—urinary bladder cancer	0.0109	0.0224	CbGbCtD
Chlorpromazine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0106	0.0218	CbGbCtD
Chlorpromazine—CHRM3—muscle of abdomen—urinary bladder cancer	0.01	0.0496	CbGeAlD
Chlorpromazine—CYP3A4—Etoposide—urinary bladder cancer	0.0099	0.0203	CbGbCtD
Chlorpromazine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00675	0.0138	CbGbCtD
Chlorpromazine—SMPD1—prostate gland—urinary bladder cancer	0.00437	0.0216	CbGeAlD
Chlorpromazine—Pigmentation disorder—Thiotepa—urinary bladder cancer	0.00426	0.0299	CcSEcCtD
Chlorpromazine—Megacolon—Methotrexate—urinary bladder cancer	0.00373	0.0262	CcSEcCtD
Chlorpromazine—CYP1A2—urine—urinary bladder cancer	0.00344	0.017	CbGeAlD
Chlorpromazine—CYP2E1—urine—urinary bladder cancer	0.0031	0.0153	CbGeAlD
Chlorpromazine—Pigmentation disorder—Etoposide—urinary bladder cancer	0.00306	0.0215	CcSEcCtD
Chlorpromazine—Thrombocytopenic purpura—Thiotepa—urinary bladder cancer	0.00303	0.0213	CcSEcCtD
Chlorpromazine—SMPD1—renal system—urinary bladder cancer	0.00298	0.0147	CbGeAlD
Chlorpromazine—Urinary retention—Valrubicin—urinary bladder cancer	0.00283	0.0199	CcSEcCtD
Chlorpromazine—HTR2A—urine—urinary bladder cancer	0.00269	0.0133	CbGeAlD
Chlorpromazine—Parkinsonism—Fluorouracil—urinary bladder cancer	0.00259	0.0182	CcSEcCtD
Chlorpromazine—CYP3A4—urine—urinary bladder cancer	0.00249	0.0123	CbGeAlD
Chlorpromazine—CYP2D6—urine—urinary bladder cancer	0.00245	0.0121	CbGeAlD
Chlorpromazine—SMPD1—female reproductive system—urinary bladder cancer	0.00239	0.0118	CbGeAlD
Chlorpromazine—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00232	0.0163	CcSEcCtD
Chlorpromazine—Sudden death—Fluorouracil—urinary bladder cancer	0.0023	0.0161	CcSEcCtD
Chlorpromazine—SMPD1—vagina—urinary bladder cancer	0.00216	0.0107	CbGeAlD
Chlorpromazine—Throat tightness—Etoposide—urinary bladder cancer	0.00208	0.0146	CcSEcCtD
Chlorpromazine—Oedema peripheral—Valrubicin—urinary bladder cancer	0.00203	0.0143	CcSEcCtD
Chlorpromazine—CALM3—prostate gland—urinary bladder cancer	0.00203	0.01	CbGeAlD
Chlorpromazine—CHRM2—prostate gland—urinary bladder cancer	0.002	0.00987	CbGeAlD
Chlorpromazine—Extrapyramidal disorder—Thiotepa—urinary bladder cancer	0.00189	0.0133	CcSEcCtD
Chlorpromazine—CHRM1—prostate gland—urinary bladder cancer	0.00182	0.00898	CbGeAlD
Chlorpromazine—ADRA1B—renal system—urinary bladder cancer	0.00181	0.00895	CbGeAlD
Chlorpromazine—DRD5—female reproductive system—urinary bladder cancer	0.00177	0.00875	CbGeAlD
Chlorpromazine—Endocrine disorder—Thiotepa—urinary bladder cancer	0.00172	0.012	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Epirubicin—urinary bladder cancer	0.00172	0.012	CcSEcCtD
Chlorpromazine—CALM3—seminal vesicle—urinary bladder cancer	0.00172	0.00848	CbGeAlD
Chlorpromazine—Retinal disorder—Methotrexate—urinary bladder cancer	0.00171	0.012	CcSEcCtD
Chlorpromazine—Pancytopenia—Mitomycin—urinary bladder cancer	0.00169	0.0118	CcSEcCtD
Chlorpromazine—CHRM3—prostate gland—urinary bladder cancer	0.00163	0.00804	CbGeAlD
Chlorpromazine—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00162	0.0114	CcSEcCtD
Chlorpromazine—CALM2—prostate gland—urinary bladder cancer	0.00159	0.00787	CbGeAlD
Chlorpromazine—Pigmentation disorder—Doxorubicin—urinary bladder cancer	0.00159	0.0111	CcSEcCtD
Chlorpromazine—CALM1—prostate gland—urinary bladder cancer	0.00159	0.00783	CbGeAlD
Chlorpromazine—Drowsiness—Mitomycin—urinary bladder cancer	0.00158	0.0111	CcSEcCtD
Chlorpromazine—ADRA1A—prostate gland—urinary bladder cancer	0.00149	0.00738	CbGeAlD
Chlorpromazine—KCNH2—prostate gland—urinary bladder cancer	0.00144	0.00713	CbGeAlD
Chlorpromazine—CALM3—smooth muscle tissue—urinary bladder cancer	0.00144	0.0071	CbGeAlD
Chlorpromazine—Dermatitis contact—Thiotepa—urinary bladder cancer	0.00141	0.00986	CcSEcCtD
Chlorpromazine—SMPD1—lymph node—urinary bladder cancer	0.0014	0.0069	CbGeAlD
Chlorpromazine—CALM3—urethra—urinary bladder cancer	0.00136	0.00671	CbGeAlD
Chlorpromazine—Infection—Carboplatin—urinary bladder cancer	0.00135	0.00946	CcSEcCtD
Chlorpromazine—CALM2—seminal vesicle—urinary bladder cancer	0.00135	0.00666	CbGeAlD
Chlorpromazine—SLC22A1—renal system—urinary bladder cancer	0.00134	0.00661	CbGeAlD
Chlorpromazine—BCHE—prostate gland—urinary bladder cancer	0.00133	0.00656	CbGeAlD
Chlorpromazine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00128	0.00633	CbGeAlD
Chlorpromazine—KCNH2—seminal vesicle—urinary bladder cancer	0.00122	0.00603	CbGeAlD
Chlorpromazine—Sudden death—Methotrexate—urinary bladder cancer	0.0012	0.00839	CcSEcCtD
Chlorpromazine—CALM2—epithelium—urinary bladder cancer	0.00117	0.00578	CbGeAlD
Chlorpromazine—CALM1—epithelium—urinary bladder cancer	0.00116	0.00576	CbGeAlD
Chlorpromazine—Dermatitis contact—Fluorouracil—urinary bladder cancer	0.00116	0.00816	CcSEcCtD
Chlorpromazine—Body temperature increased—Valrubicin—urinary bladder cancer	0.00116	0.00813	CcSEcCtD
Chlorpromazine—HRH1—prostate gland—urinary bladder cancer	0.00116	0.00571	CbGeAlD
Chlorpromazine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00115	0.00569	CbGeAlD
Chlorpromazine—HTR7—epithelium—urinary bladder cancer	0.00114	0.00562	CbGeAlD
Chlorpromazine—ADRA2A—prostate gland—urinary bladder cancer	0.00114	0.00561	CbGeAlD
Chlorpromazine—CALM2—smooth muscle tissue—urinary bladder cancer	0.00113	0.00557	CbGeAlD
Chlorpromazine—BCHE—seminal vesicle—urinary bladder cancer	0.00112	0.00555	CbGeAlD
Chlorpromazine—CALM1—smooth muscle tissue—urinary bladder cancer	0.00112	0.00555	CbGeAlD
Chlorpromazine—CYP2E1—prostate gland—urinary bladder cancer	0.00111	0.00549	CbGeAlD
Chlorpromazine—Syncope—Mitomycin—urinary bladder cancer	0.00111	0.00778	CcSEcCtD
Chlorpromazine—CHRM3—renal system—urinary bladder cancer	0.00111	0.00548	CbGeAlD
Chlorpromazine—Leukopenia—Mitomycin—urinary bladder cancer	0.00111	0.00777	CcSEcCtD
Chlorpromazine—HTR1A—renal system—urinary bladder cancer	0.0011	0.00546	CbGeAlD
Chlorpromazine—ADRA1A—epithelium—urinary bladder cancer	0.0011	0.00542	CbGeAlD
Chlorpromazine—HTR7—smooth muscle tissue—urinary bladder cancer	0.0011	0.00542	CbGeAlD
Chlorpromazine—CHRM3—urethra—urinary bladder cancer	0.00109	0.00538	CbGeAlD
Chlorpromazine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00109	0.00763	CcSEcCtD
Chlorpromazine—CALM2—renal system—urinary bladder cancer	0.00109	0.00536	CbGeAlD
Chlorpromazine—CALM1—renal system—urinary bladder cancer	0.00108	0.00534	CbGeAlD
Chlorpromazine—Cough—Mitomycin—urinary bladder cancer	0.00108	0.00757	CcSEcCtD
Chlorpromazine—Body temperature increased—Carboplatin—urinary bladder cancer	0.00107	0.00753	CcSEcCtD
Chlorpromazine—CALM2—urethra—urinary bladder cancer	0.00107	0.00527	CbGeAlD
Chlorpromazine—CALM1—urethra—urinary bladder cancer	0.00106	0.00524	CbGeAlD
Chlorpromazine—HTR7—renal system—urinary bladder cancer	0.00106	0.00522	CbGeAlD
Chlorpromazine—HTR2C—female reproductive system—urinary bladder cancer	0.00105	0.00519	CbGeAlD
Chlorpromazine—ADRA1A—renal system—urinary bladder cancer	0.00102	0.00503	CbGeAlD
Chlorpromazine—CALM3—vagina—urinary bladder cancer	0.001	0.00495	CbGeAlD
Chlorpromazine—Shock—Mitomycin—urinary bladder cancer	0.000993	0.00697	CcSEcCtD
Chlorpromazine—CHRM1—female reproductive system—urinary bladder cancer	0.000993	0.0049	CbGeAlD
Chlorpromazine—HTR2B—female reproductive system—urinary bladder cancer	0.000987	0.00488	CbGeAlD
Chlorpromazine—KCNH2—renal system—urinary bladder cancer	0.000983	0.00486	CbGeAlD
Chlorpromazine—Urinary retention—Thiotepa—urinary bladder cancer	0.000982	0.00689	CcSEcCtD
Chlorpromazine—Cardiac arrest—Thiotepa—urinary bladder cancer	0.000982	0.00689	CcSEcCtD
Chlorpromazine—Photosensitivity—Fluorouracil—urinary bladder cancer	0.000973	0.00683	CcSEcCtD
Chlorpromazine—Dizziness—Valrubicin—urinary bladder cancer	0.000969	0.0068	CcSEcCtD
Chlorpromazine—SLC22A1—vagina—urinary bladder cancer	0.000969	0.00479	CbGeAlD
Chlorpromazine—KCNH2—urethra—urinary bladder cancer	0.000966	0.00477	CbGeAlD
Chlorpromazine—ADRA2A—seminal vesicle—urinary bladder cancer	0.000961	0.00475	CbGeAlD
Chlorpromazine—BCHE—smooth muscle tissue—urinary bladder cancer	0.00094	0.00465	CbGeAlD
Chlorpromazine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00094	0.00464	CbGeAlD
Chlorpromazine—Dyspnoea—Mitomycin—urinary bladder cancer	0.0009	0.00631	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.000898	0.0063	CcSEcCtD
Chlorpromazine—Somnolence—Mitomycin—urinary bladder cancer	0.000897	0.0063	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.000897	0.00629	CcSEcCtD
Chlorpromazine—HTR2B—vagina—urinary bladder cancer	0.000893	0.00441	CbGeAlD
Chlorpromazine—Nasal congestion—Cisplatin—urinary bladder cancer	0.000889	0.00624	CcSEcCtD
Chlorpromazine—CHRM3—female reproductive system—urinary bladder cancer	0.000888	0.00439	CbGeAlD
Chlorpromazine—CALM2—female reproductive system—urinary bladder cancer	0.000869	0.0043	CbGeAlD
Chlorpromazine—CALM1—female reproductive system—urinary bladder cancer	0.000865	0.00428	CbGeAlD
Chlorpromazine—HRH1—epithelium—urinary bladder cancer	0.00085	0.0042	CbGeAlD
Chlorpromazine—Pancytopenia—Thiotepa—urinary bladder cancer	0.000848	0.00595	CcSEcCtD
Chlorpromazine—HTR7—female reproductive system—urinary bladder cancer	0.000845	0.00418	CbGeAlD
Chlorpromazine—CYP1A2—renal system—urinary bladder cancer	0.000842	0.00416	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.000837	0.00587	CcSEcCtD
Chlorpromazine—HRH1—smooth muscle tissue—urinary bladder cancer	0.000819	0.00405	CbGeAlD
Chlorpromazine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.000812	0.0057	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.000805	0.00565	CcSEcCtD
Chlorpromazine—Body temperature increased—Mitomycin—urinary bladder cancer	0.000798	0.0056	CcSEcCtD
Chlorpromazine—KCNH2—female reproductive system—urinary bladder cancer	0.000788	0.00389	CbGeAlD
Chlorpromazine—CALM2—vagina—urinary bladder cancer	0.000786	0.00389	CbGeAlD
Chlorpromazine—CALM1—vagina—urinary bladder cancer	0.000783	0.00387	CbGeAlD
Chlorpromazine—Jaundice—Thiotepa—urinary bladder cancer	0.000776	0.00544	CcSEcCtD
Chlorpromazine—HRH1—urethra—urinary bladder cancer	0.000774	0.00383	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.000766	0.00538	CcSEcCtD
Chlorpromazine—ADRA2A—urethra—urinary bladder cancer	0.000761	0.00376	CbGeAlD
Chlorpromazine—CYP2E1—renal system—urinary bladder cancer	0.000757	0.00374	CbGeAlD
Chlorpromazine—Influenza—Gemcitabine—urinary bladder cancer	0.000751	0.00527	CcSEcCtD
Chlorpromazine—CYP2E1—urethra—urinary bladder cancer	0.000744	0.00368	CbGeAlD
Chlorpromazine—Agranulocytosis—Thiotepa—urinary bladder cancer	0.000743	0.00521	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00074	0.00519	CcSEcCtD
Chlorpromazine—Dysphagia—Fluorouracil—urinary bladder cancer	0.000738	0.00518	CcSEcCtD
Chlorpromazine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000731	0.00513	CcSEcCtD
Chlorpromazine—BCHE—female reproductive system—urinary bladder cancer	0.000725	0.00358	CbGeAlD
Chlorpromazine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000713	0.005	CcSEcCtD
Chlorpromazine—KCNH2—vagina—urinary bladder cancer	0.000712	0.00352	CbGeAlD
Chlorpromazine—HTR2A—epithelium—urinary bladder cancer	0.00071	0.00351	CbGeAlD
Chlorpromazine—Glycosuria—Epirubicin—urinary bladder cancer	0.000707	0.00496	CcSEcCtD
Chlorpromazine—Cardiac arrest—Etoposide—urinary bladder cancer	0.000705	0.00495	CcSEcCtD
Chlorpromazine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000701	0.00492	CcSEcCtD
Chlorpromazine—Blood disorder—Epirubicin—urinary bladder cancer	0.000686	0.00481	CcSEcCtD
Chlorpromazine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.000684	0.00338	CbGeAlD
Chlorpromazine—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000677	0.00475	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.000674	0.00473	CcSEcCtD
Chlorpromazine—Dizziness—Mitomycin—urinary bladder cancer	0.000667	0.00468	CcSEcCtD
Chlorpromazine—Pancytopenia—Cisplatin—urinary bladder cancer	0.000665	0.00466	CcSEcCtD
Chlorpromazine—HTR2A—renal system—urinary bladder cancer	0.000658	0.00325	CbGeAlD
Chlorpromazine—BCHE—vagina—urinary bladder cancer	0.000656	0.00324	CbGeAlD
Chlorpromazine—Glycosuria—Doxorubicin—urinary bladder cancer	0.000654	0.00459	CcSEcCtD
Chlorpromazine—Amenorrhoea—Epirubicin—urinary bladder cancer	0.000652	0.00457	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.000652	0.00457	CcSEcCtD
Chlorpromazine—CALM3—lymph node—urinary bladder cancer	0.000648	0.0032	CbGeAlD
Chlorpromazine—Dysphagia—Etoposide—urinary bladder cancer	0.000641	0.0045	CcSEcCtD
Chlorpromazine—Blood disorder—Doxorubicin—urinary bladder cancer	0.000635	0.00445	CcSEcCtD
Chlorpromazine—ABCB1—prostate gland—urinary bladder cancer	0.000633	0.00313	CbGeAlD
Chlorpromazine—HRH1—female reproductive system—urinary bladder cancer	0.000631	0.00312	CbGeAlD
Chlorpromazine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000625	0.00438	CcSEcCtD
Chlorpromazine—ADRA2A—female reproductive system—urinary bladder cancer	0.00062	0.00306	CbGeAlD
Chlorpromazine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000614	0.00431	CcSEcCtD
Chlorpromazine—Dyskinesia—Epirubicin—urinary bladder cancer	0.00061	0.00428	CcSEcCtD
Chlorpromazine—CYP3A4—renal system—urinary bladder cancer	0.000609	0.00301	CbGeAlD
Chlorpromazine—Pancytopenia—Etoposide—urinary bladder cancer	0.000609	0.00427	CcSEcCtD
Chlorpromazine—CYP2E1—female reproductive system—urinary bladder cancer	0.000607	0.003	CbGeAlD
Chlorpromazine—Nervousness—Thiotepa—urinary bladder cancer	0.000604	0.00424	CcSEcCtD
Chlorpromazine—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000603	0.00423	CcSEcCtD
Chlorpromazine—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.000603	0.00423	CcSEcCtD
Chlorpromazine—ALB—lymph node—urinary bladder cancer	0.0006	0.00296	CbGeAlD
Chlorpromazine—CYP2D6—renal system—urinary bladder cancer	0.0006	0.00296	CbGeAlD
Chlorpromazine—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.000592	0.00415	CcSEcCtD
Chlorpromazine—Gait disturbance—Epirubicin—urinary bladder cancer	0.000587	0.00412	CcSEcCtD
Chlorpromazine—HTR2B—lymph node—urinary bladder cancer	0.000578	0.00285	CbGeAlD
Chlorpromazine—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.000575	0.00403	CcSEcCtD
Chlorpromazine—HRH1—vagina—urinary bladder cancer	0.000571	0.00282	CbGeAlD
Chlorpromazine—Dermatitis contact—Epirubicin—urinary bladder cancer	0.000566	0.00397	CcSEcCtD
Chlorpromazine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.000564	0.00396	CcSEcCtD
Chlorpromazine—ADRA2A—vagina—urinary bladder cancer	0.000561	0.00277	CbGeAlD
Chlorpromazine—Jaundice—Etoposide—urinary bladder cancer	0.000557	0.00391	CcSEcCtD
Chlorpromazine—Leukopenia—Thiotepa—urinary bladder cancer	0.000557	0.00391	CcSEcCtD
Chlorpromazine—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000548	0.00384	CcSEcCtD
Chlorpromazine—Gait disturbance—Doxorubicin—urinary bladder cancer	0.000543	0.00381	CcSEcCtD
Chlorpromazine—Cough—Thiotepa—urinary bladder cancer	0.000543	0.00381	CcSEcCtD
Chlorpromazine—Visual impairment—Cisplatin—urinary bladder cancer	0.00054	0.00379	CcSEcCtD
Chlorpromazine—Convulsion—Thiotepa—urinary bladder cancer	0.000539	0.00378	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000538	0.00377	CcSEcCtD
Chlorpromazine—ABCB1—seminal vesicle—urinary bladder cancer	0.000535	0.00264	CbGeAlD
Chlorpromazine—Agranulocytosis—Etoposide—urinary bladder cancer	0.000533	0.00374	CcSEcCtD
Chlorpromazine—HTR2A—female reproductive system—urinary bladder cancer	0.000527	0.0026	CbGeAlD
Chlorpromazine—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.000524	0.00368	CcSEcCtD
Chlorpromazine—CALM2—lymph node—urinary bladder cancer	0.000509	0.00251	CbGeAlD
Chlorpromazine—CALM1—lymph node—urinary bladder cancer	0.000506	0.0025	CbGeAlD
Chlorpromazine—Photosensitivity—Methotrexate—urinary bladder cancer	0.000506	0.00355	CcSEcCtD
Chlorpromazine—Infection—Thiotepa—urinary bladder cancer	0.000504	0.00354	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000498	0.00349	CcSEcCtD
Chlorpromazine—Tachycardia—Thiotepa—urinary bladder cancer	0.000495	0.00348	CcSEcCtD
Chlorpromazine—CYP3A4—female reproductive system—urinary bladder cancer	0.000488	0.00241	CbGeAlD
Chlorpromazine—CYP2D6—female reproductive system—urinary bladder cancer	0.00048	0.00237	CbGeAlD
Chlorpromazine—HTR2A—vagina—urinary bladder cancer	0.000477	0.00236	CbGeAlD
Chlorpromazine—Photosensitivity—Epirubicin—urinary bladder cancer	0.000474	0.00332	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000471	0.0033	CcSEcCtD
Chlorpromazine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000469	0.00329	CcSEcCtD
Chlorpromazine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000468	0.00329	CcSEcCtD
Chlorpromazine—ABCB1—epithelium—urinary bladder cancer	0.000465	0.0023	CbGeAlD
Chlorpromazine—KCNH2—lymph node—urinary bladder cancer	0.000461	0.00228	CbGeAlD
Chlorpromazine—Leukopenia—Fluorouracil—urinary bladder cancer	0.00046	0.00323	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000459	0.00322	CcSEcCtD
Chlorpromazine—Tremor—Cisplatin—urinary bladder cancer	0.000457	0.00321	CcSEcCtD
Chlorpromazine—Cough—Gemcitabine—urinary bladder cancer	0.000457	0.0032	CcSEcCtD
Chlorpromazine—Somnolence—Thiotepa—urinary bladder cancer	0.000451	0.00317	CcSEcCtD
Chlorpromazine—Convulsion—Fluorouracil—urinary bladder cancer	0.000446	0.00313	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000441	0.00309	CcSEcCtD
Chlorpromazine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.000438	0.00307	CcSEcCtD
Chlorpromazine—Leukopenia—Cisplatin—urinary bladder cancer	0.000436	0.00306	CcSEcCtD
Chlorpromazine—Constipation—Thiotepa—urinary bladder cancer	0.000434	0.00305	CcSEcCtD
Chlorpromazine—ABCB1—renal system—urinary bladder cancer	0.000431	0.00213	CbGeAlD
Chlorpromazine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00043	0.00301	CcSEcCtD
Chlorpromazine—Muscle spasms—Etoposide—urinary bladder cancer	0.00043	0.00301	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000427	0.003	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000426	0.00299	CcSEcCtD
Chlorpromazine—Infection—Gemcitabine—urinary bladder cancer	0.000424	0.00298	CcSEcCtD
Chlorpromazine—BCHE—lymph node—urinary bladder cancer	0.000424	0.0021	CbGeAlD
Chlorpromazine—ABCB1—urethra—urinary bladder cancer	0.000424	0.00209	CbGeAlD
Chlorpromazine—Convulsion—Cisplatin—urinary bladder cancer	0.000423	0.00296	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00042	0.00295	CcSEcCtD
Chlorpromazine—Infection—Fluorouracil—urinary bladder cancer	0.000417	0.00293	CcSEcCtD
Chlorpromazine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00041	0.00287	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000408	0.00286	CcSEcCtD
Chlorpromazine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000401	0.00282	CcSEcCtD
Chlorpromazine—Leukopenia—Etoposide—urinary bladder cancer	0.0004	0.00281	CcSEcCtD
Chlorpromazine—Hypotension—Gemcitabine—urinary bladder cancer	0.000399	0.0028	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000398	0.00279	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000398	0.00279	CcSEcCtD
Chlorpromazine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000395	0.00277	CcSEcCtD
Chlorpromazine—Infection—Cisplatin—urinary bladder cancer	0.000395	0.00277	CcSEcCtD
Chlorpromazine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000394	0.00277	CcSEcCtD
Chlorpromazine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000393	0.00275	CcSEcCtD
Chlorpromazine—Hypotension—Fluorouracil—urinary bladder cancer	0.000392	0.00275	CcSEcCtD
Chlorpromazine—Cough—Etoposide—urinary bladder cancer	0.00039	0.00274	CcSEcCtD
Chlorpromazine—Tachycardia—Cisplatin—urinary bladder cancer	0.000388	0.00273	CcSEcCtD
Chlorpromazine—Convulsion—Etoposide—urinary bladder cancer	0.000387	0.00272	CcSEcCtD
Chlorpromazine—Insomnia—Gemcitabine—urinary bladder cancer	0.000386	0.00271	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—urinary bladder cancer	0.000384	0.00269	CcSEcCtD
Chlorpromazine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000381	0.00267	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00038	0.00267	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00038	0.00266	CcSEcCtD
Chlorpromazine—Insomnia—Fluorouracil—urinary bladder cancer	0.00038	0.00266	CcSEcCtD
Chlorpromazine—Somnolence—Gemcitabine—urinary bladder cancer	0.00038	0.00266	CcSEcCtD
Chlorpromazine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000374	0.00263	CcSEcCtD
Chlorpromazine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000374	0.00262	CcSEcCtD
Chlorpromazine—Somnolence—Fluorouracil—urinary bladder cancer	0.000373	0.00262	CcSEcCtD
Chlorpromazine—Hypotension—Cisplatin—urinary bladder cancer	0.000372	0.00261	CcSEcCtD
Chlorpromazine—HRH1—lymph node—urinary bladder cancer	0.000369	0.00182	CbGeAlD
Chlorpromazine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000366	0.00257	CcSEcCtD
Chlorpromazine—Constipation—Gemcitabine—urinary bladder cancer	0.000365	0.00256	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000365	0.00256	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000365	0.00256	CcSEcCtD
Chlorpromazine—ADRA2A—lymph node—urinary bladder cancer	0.000363	0.00179	CbGeAlD
Chlorpromazine—Infection—Etoposide—urinary bladder cancer	0.000362	0.00254	CcSEcCtD
Chlorpromazine—Dysphagia—Epirubicin—urinary bladder cancer	0.000359	0.00252	CcSEcCtD
Chlorpromazine—Asthma—Epirubicin—urinary bladder cancer	0.000359	0.00252	CcSEcCtD
Chlorpromazine—Influenza—Epirubicin—urinary bladder cancer	0.000359	0.00252	CcSEcCtD
Chlorpromazine—Tachycardia—Etoposide—urinary bladder cancer	0.000356	0.0025	CcSEcCtD
Chlorpromazine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000356	0.0025	CcSEcCtD
Chlorpromazine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000355	0.00249	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000354	0.00248	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000351	0.00247	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000351	0.00246	CcSEcCtD
Chlorpromazine—ABCB1—female reproductive system—urinary bladder cancer	0.000345	0.00171	CbGeAlD
Chlorpromazine—Drowsiness—Methotrexate—urinary bladder cancer	0.000342	0.0024	CcSEcCtD
Chlorpromazine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000341	0.00239	CcSEcCtD
Chlorpromazine—Hypotension—Etoposide—urinary bladder cancer	0.000341	0.00239	CcSEcCtD
Chlorpromazine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000338	0.00237	CcSEcCtD
Chlorpromazine—Dizziness—Thiotepa—urinary bladder cancer	0.000336	0.00236	CcSEcCtD
Chlorpromazine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000333	0.00233	CcSEcCtD
Chlorpromazine—Influenza—Doxorubicin—urinary bladder cancer	0.000333	0.00233	CcSEcCtD
Chlorpromazine—Asthma—Doxorubicin—urinary bladder cancer	0.000333	0.00233	CcSEcCtD
Chlorpromazine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000332	0.00233	CcSEcCtD
Chlorpromazine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000329	0.00231	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000328	0.0023	CcSEcCtD
Chlorpromazine—Dyspnoea—Etoposide—urinary bladder cancer	0.000325	0.00228	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000324	0.00227	CcSEcCtD
Chlorpromazine—Somnolence—Etoposide—urinary bladder cancer	0.000324	0.00227	CcSEcCtD
Chlorpromazine—Drowsiness—Epirubicin—urinary bladder cancer	0.00032	0.00225	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00032	0.00224	CcSEcCtD
Chlorpromazine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000316	0.00222	CcSEcCtD
Chlorpromazine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000315	0.00221	CcSEcCtD
Chlorpromazine—ABCB1—vagina—urinary bladder cancer	0.000312	0.00154	CbGeAlD
Chlorpromazine—Jaundice—Epirubicin—urinary bladder cancer	0.000312	0.00219	CcSEcCtD
Chlorpromazine—Constipation—Etoposide—urinary bladder cancer	0.000312	0.00219	CcSEcCtD
Chlorpromazine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000309	0.00217	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000304	0.00213	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.0003	0.0021	CcSEcCtD
Chlorpromazine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000299	0.0021	CcSEcCtD
Chlorpromazine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000297	0.00208	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—urinary bladder cancer	0.000296	0.00208	CcSEcCtD
Chlorpromazine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000293	0.00206	CcSEcCtD
Chlorpromazine—Jaundice—Doxorubicin—urinary bladder cancer	0.000289	0.00203	CcSEcCtD
Chlorpromazine—Body temperature increased—Etoposide—urinary bladder cancer	0.000288	0.00202	CcSEcCtD
Chlorpromazine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000283	0.00199	CcSEcCtD
Chlorpromazine—Dizziness—Fluorouracil—urinary bladder cancer	0.000278	0.00195	CcSEcCtD
Chlorpromazine—Visual impairment—Epirubicin—urinary bladder cancer	0.000277	0.00195	CcSEcCtD
Chlorpromazine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000277	0.00194	CcSEcCtD
Chlorpromazine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000269	0.00188	CcSEcCtD
Chlorpromazine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000262	0.00184	CcSEcCtD
Chlorpromazine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000257	0.0018	CcSEcCtD
Chlorpromazine—Nervousness—Epirubicin—urinary bladder cancer	0.000243	0.00171	CcSEcCtD
Chlorpromazine—Dizziness—Etoposide—urinary bladder cancer	0.000241	0.00169	CcSEcCtD
Chlorpromazine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000241	0.00169	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—urinary bladder cancer	0.00024	0.00168	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—urinary bladder cancer	0.000234	0.00164	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—urinary bladder cancer	0.000232	0.00163	CcSEcCtD
Chlorpromazine—Nervousness—Doxorubicin—urinary bladder cancer	0.000225	0.00158	CcSEcCtD
Chlorpromazine—Syncope—Epirubicin—urinary bladder cancer	0.000225	0.00158	CcSEcCtD
Chlorpromazine—Leukopenia—Epirubicin—urinary bladder cancer	0.000224	0.00157	CcSEcCtD
Chlorpromazine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000223	0.00156	CcSEcCtD
Chlorpromazine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00022	0.00154	CcSEcCtD
Chlorpromazine—Cough—Epirubicin—urinary bladder cancer	0.000219	0.00153	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000218	0.00153	CcSEcCtD
Chlorpromazine—Convulsion—Epirubicin—urinary bladder cancer	0.000217	0.00152	CcSEcCtD
Chlorpromazine—Infection—Methotrexate—urinary bladder cancer	0.000217	0.00152	CcSEcCtD
Chlorpromazine—Dry mouth—Epirubicin—urinary bladder cancer	0.000209	0.00146	CcSEcCtD
Chlorpromazine—Syncope—Doxorubicin—urinary bladder cancer	0.000208	0.00146	CcSEcCtD
Chlorpromazine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000207	0.00146	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000204	0.00143	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—urinary bladder cancer	0.000204	0.00143	CcSEcCtD
Chlorpromazine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000204	0.00143	CcSEcCtD
Chlorpromazine—Infection—Epirubicin—urinary bladder cancer	0.000203	0.00142	CcSEcCtD
Chlorpromazine—Cough—Doxorubicin—urinary bladder cancer	0.000202	0.00142	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—urinary bladder cancer	0.000202	0.000999	CbGeAlD
Chlorpromazine—Shock—Epirubicin—urinary bladder cancer	0.000201	0.00141	CcSEcCtD
Chlorpromazine—Convulsion—Doxorubicin—urinary bladder cancer	0.000201	0.00141	CcSEcCtD
Chlorpromazine—Tachycardia—Epirubicin—urinary bladder cancer	0.000199	0.0014	CcSEcCtD
Chlorpromazine—Insomnia—Methotrexate—urinary bladder cancer	0.000198	0.00139	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000195	0.00137	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—urinary bladder cancer	0.000194	0.00136	CcSEcCtD
Chlorpromazine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000193	0.00135	CcSEcCtD
Chlorpromazine—Hypotension—Epirubicin—urinary bladder cancer	0.000191	0.00134	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000189	0.00133	CcSEcCtD
Chlorpromazine—Infection—Doxorubicin—urinary bladder cancer	0.000188	0.00132	CcSEcCtD
Chlorpromazine—Shock—Doxorubicin—urinary bladder cancer	0.000186	0.00131	CcSEcCtD
Chlorpromazine—Insomnia—Epirubicin—urinary bladder cancer	0.000185	0.0013	CcSEcCtD
Chlorpromazine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000185	0.00129	CcSEcCtD
Chlorpromazine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000182	0.00128	CcSEcCtD
Chlorpromazine—Somnolence—Epirubicin—urinary bladder cancer	0.000182	0.00127	CcSEcCtD
Chlorpromazine—Hypotension—Doxorubicin—urinary bladder cancer	0.000177	0.00124	CcSEcCtD
Chlorpromazine—Constipation—Epirubicin—urinary bladder cancer	0.000175	0.00123	CcSEcCtD
Chlorpromazine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000173	0.00121	CcSEcCtD
Chlorpromazine—Insomnia—Doxorubicin—urinary bladder cancer	0.000171	0.0012	CcSEcCtD
Chlorpromazine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000169	0.00118	CcSEcCtD
Chlorpromazine—Somnolence—Doxorubicin—urinary bladder cancer	0.000168	0.00118	CcSEcCtD
Chlorpromazine—Constipation—Doxorubicin—urinary bladder cancer	0.000162	0.00113	CcSEcCtD
Chlorpromazine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000162	0.00113	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000161	0.00113	CcSEcCtD
Chlorpromazine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000151	0.00106	CcSEcCtD
Chlorpromazine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000149	0.00105	CcSEcCtD
Chlorpromazine—Dizziness—Methotrexate—urinary bladder cancer	0.000144	0.00101	CcSEcCtD
Chlorpromazine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000139	0.000978	CcSEcCtD
Chlorpromazine—Dizziness—Epirubicin—urinary bladder cancer	0.000135	0.000948	CcSEcCtD
Chlorpromazine—Dizziness—Doxorubicin—urinary bladder cancer	0.000125	0.000877	CcSEcCtD
Chlorpromazine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	7.24e-06	4.33e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	7.24e-06	4.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	7.22e-06	4.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	7.2e-06	4.3e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	7.18e-06	4.3e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	7.18e-06	4.29e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	7.18e-06	4.29e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	7.18e-06	4.29e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	7.14e-06	4.27e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	7.1e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—urinary bladder cancer	7.1e-06	4.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	7.1e-06	4.24e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	7.09e-06	4.24e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—SRC—urinary bladder cancer	7.07e-06	4.23e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—SRC—urinary bladder cancer	7.07e-06	4.23e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	7.07e-06	4.23e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	7.05e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	7.03e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	7.01e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.01e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	7e-06	4.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	6.99e-06	4.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	6.99e-06	4.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	6.94e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	6.94e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—EGFR—urinary bladder cancer	6.94e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	6.94e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	6.92e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—EP300—urinary bladder cancer	6.9e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	6.89e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	6.88e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	6.88e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.87e-06	4.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	6.85e-06	4.1e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	6.83e-06	4.09e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.82e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	6.8e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	6.8e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—HRAS—urinary bladder cancer	6.79e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	6.79e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	6.78e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	6.78e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	6.78e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	6.77e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	6.77e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	6.77e-06	4.05e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	6.76e-06	4.04e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	6.75e-06	4.04e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	6.73e-06	4.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—EGFR—urinary bladder cancer	6.72e-06	4.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—EGFR—urinary bladder cancer	6.72e-06	4.02e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	6.69e-06	4e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	6.69e-06	4e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	6.68e-06	3.99e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.67e-06	3.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	6.66e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.65e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	6.65e-06	3.98e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	6.65e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	6.64e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	6.63e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.63e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	6.62e-06	3.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	6.61e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.6e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTEN—urinary bladder cancer	6.6e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	6.6e-06	3.94e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	6.57e-06	3.93e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KRAS—urinary bladder cancer	6.56e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MYC—urinary bladder cancer	6.55e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	6.55e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—urinary bladder cancer	6.55e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	6.55e-06	3.91e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	6.53e-06	3.91e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.53e-06	3.9e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	6.51e-06	3.89e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	6.49e-06	3.88e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	6.48e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	6.48e-06	3.87e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	6.45e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	6.43e-06	3.85e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—EGFR—urinary bladder cancer	6.41e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	6.4e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTEN—urinary bladder cancer	6.39e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTEN—urinary bladder cancer	6.39e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	6.37e-06	3.81e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KRAS—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KRAS—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MYC—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MYC—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—EP300—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	6.33e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	6.31e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—EP300—urinary bladder cancer	6.3e-06	3.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	6.29e-06	3.76e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.27e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.27e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	6.27e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	6.27e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	6.26e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	6.26e-06	3.75e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	6.26e-06	3.74e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	6.23e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	6.23e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	6.21e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—EGFR—urinary bladder cancer	6.2e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—EGFR—urinary bladder cancer	6.2e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	6.2e-06	3.71e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	6.17e-06	3.69e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	6.16e-06	3.68e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	6.14e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	6.14e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	6.12e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	6.11e-06	3.65e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	6.1e-06	3.65e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	6.09e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—EP300—urinary bladder cancer	6.09e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—EP300—urinary bladder cancer	6.09e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	6.09e-06	3.64e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.07e-06	3.63e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	6.06e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—KRAS—urinary bladder cancer	6.05e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	6.05e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	6.04e-06	3.61e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	6.03e-06	3.61e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.01e-06	3.59e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	5.96e-06	3.56e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	5.94e-06	3.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	5.94e-06	3.55e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	5.91e-06	3.54e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	5.9e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	5.9e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.9e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	5.88e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL2—urinary bladder cancer	5.87e-06	3.51e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—KRAS—urinary bladder cancer	5.86e-06	3.5e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—KRAS—urinary bladder cancer	5.86e-06	3.5e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	5.84e-06	3.49e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.82e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	5.77e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	5.77e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.74e-06	3.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	5.72e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—urinary bladder cancer	5.71e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL2—urinary bladder cancer	5.68e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL2—urinary bladder cancer	5.68e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	5.63e-06	3.37e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	5.62e-06	3.36e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	5.61e-06	3.36e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.59e-06	3.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—urinary bladder cancer	5.57e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	5.55e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.54e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	5.53e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	5.53e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	5.53e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	5.53e-06	3.31e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	5.52e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	5.52e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	5.5e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	5.49e-06	3.29e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	5.48e-06	3.28e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—EP300—urinary bladder cancer	5.45e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	5.43e-06	3.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	5.41e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.41e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	5.41e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	5.4e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—urinary bladder cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—urinary bladder cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	5.38e-06	3.22e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	5.37e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	5.37e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	5.36e-06	3.21e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	5.35e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.35e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	5.34e-06	3.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	5.34e-06	3.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	5.31e-06	3.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	5.29e-06	3.17e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EP300—urinary bladder cancer	5.27e-06	3.15e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	5.25e-06	3.14e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	5.23e-06	3.13e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	5.19e-06	3.1e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—urinary bladder cancer	5.15e-06	3.08e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—SRC—urinary bladder cancer	5.12e-06	3.06e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	5.11e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	5.1e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EP300—urinary bladder cancer	5.09e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EP300—urinary bladder cancer	5.09e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	5.08e-06	3.04e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	5.06e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	5.03e-06	3.01e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	5.03e-06	3.01e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	5.02e-06	3e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—urinary bladder cancer	5e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	5e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	5e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	5e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—urinary bladder cancer	4.98e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—urinary bladder cancer	4.98e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SRC—urinary bladder cancer	4.95e-06	2.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SRC—urinary bladder cancer	4.95e-06	2.96e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	4.92e-06	2.94e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	4.79e-06	2.86e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.77e-06	2.85e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.72e-06	2.82e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	4.65e-06	2.78e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	4.61e-06	2.76e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—urinary bladder cancer	4.59e-06	2.74e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.58e-06	2.74e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	4.54e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	4.53e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	4.52e-06	2.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	4.5e-06	2.69e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.5e-06	2.69e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.49e-06	2.69e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	4.49e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	4.46e-06	2.67e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	4.45e-06	2.66e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—urinary bladder cancer	4.44e-06	2.65e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—urinary bladder cancer	4.44e-06	2.65e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	4.41e-06	2.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	4.34e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	4.34e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	4.34e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	4.33e-06	2.59e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	4.32e-06	2.58e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.32e-06	2.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	4.3e-06	2.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	4.26e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	4.25e-06	2.54e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	4.24e-06	2.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	4.13e-06	2.47e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	4.1e-06	2.45e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	4.1e-06	2.45e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4e-06	2.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	3.95e-06	2.36e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.81e-06	2.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—urinary bladder cancer	3.77e-06	2.25e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—urinary bladder cancer	3.65e-06	2.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—urinary bladder cancer	3.65e-06	2.18e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	3.6e-06	2.16e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.54e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	3.49e-06	2.08e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	3.49e-06	2.08e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.08e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.94e-06	1.76e-05	CbGpPWpGaD
